Black Rock Inc. Taysha Gene Therapies, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 11,742,449 shares of TSHA stock, worth $25.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,742,449

Previous 2,597,303 352.1%

Holding current value

$25.6 Million

Previous $7.45 Million 252.87%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.04 - $4.17 $18.7 Million - $38.1 Million	9,145,146 Added 352.1%	11,742,449 $26.3 Million
Q1 2024 May 10, 2024	SELL	$1.43 - $3.25 $145,767 - $331,288	-101,935 Reduced 3.78%	2,597,303 $7.45 Million
Q4 2023 Feb 13, 2024	BUY	$1.33 - $2.88 $2.6 Million - $5.62 Million	1,951,170 Added 260.83%	2,699,238 $4.78 Million
Q3 2023 Nov 13, 2023	BUY	$0.63 - $3.66 $269,037 - $1.56 Million	427,043 Added 133.02%	748,068 $2.36 Million
Q2 2023 Aug 11, 2023	SELL	$0.59 - $0.87 $45,111 - $66,520	-76,460 Reduced 19.24%	321,025 $211,000
Q1 2023 May 12, 2023	SELL	$0.65 - $2.3 $205,771 - $728,115	-316,572 Reduced 44.33%	397,485 $317,000
Q4 2022 Feb 13, 2023	SELL	$1.39 - $2.98 $447,012 - $958,344	-321,592 Reduced 31.05%	714,057 $1.61 Million
Q3 2022 Nov 14, 2022	SELL	$1.76 - $4.94 $19,080 - $53,554	-10,841 Reduced 1.04%	1,035,649 $2 Million
Q2 2022 Aug 12, 2022	SELL	$2.47 - $6.77 $2.83 Million - $7.77 Million	-1,147,213 Reduced 52.3%	1,046,490 $3.89 Million
Q1 2022 May 12, 2022	SELL	$5.22 - $11.86 $4.38 Million - $9.95 Million	-839,260 Reduced 27.67%	2,193,703 $14.3 Million
Q4 2021 Feb 10, 2022	BUY	$11.43 - $19.2 $125,661 - $211,084	10,994 Added 0.36%	3,032,963 $35.3 Million
Q3 2021 Nov 09, 2021	BUY	$15.82 - $21.57 $873,232 - $1.19 Million	55,198 Added 1.86%	3,021,969 $56.3 Million
Q2 2021 Aug 11, 2021	BUY	$19.29 - $26.38 $57.2 Million - $78.3 Million	2,966,771 New	2,966,771 $62.9 Million

Others Institutions Holding TSHA

# of Institutions

119

Shares Held

136M

Call Options Held

25.9K

Put Options Held

24K

View Full List

About Taysha Gene Therapies, Inc.

Ticker TSHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,359,500
Market Cap $105M
Description
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...

More about TSHA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account